1. Home
  2. ACHV vs FT Comparison

ACHV vs FT Comparison

Compare ACHV & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.27

Market Cap

233.7M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Universal Trust

FT

Franklin Universal Trust

HOLD

Current Price

$8.16

Market Cap

199.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
FT
Founded
N/A
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
233.7M
199.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
FT
Price
$4.27
$8.16
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
369.9K
66.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
7.85%
EPS Growth
17.33
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$6.71
52 Week High
$6.03
$8.35

Technical Indicators

Market Signals
Indicator
ACHV
FT
Relative Strength Index (RSI) 45.30 48.48
Support Level $4.24 $7.79
Resistance Level $4.78 $8.20
Average True Range (ATR) 0.23 0.08
MACD 0.02 -0.01
Stochastic Oscillator 32.62 32.61

Price Performance

Historical Comparison
ACHV
FT

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

Share on Social Networks: